Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the risk of therapy-related MDS/AML after autologous stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 1 Jan 2002

Gilliland D Gary, Gribben John G

Abstract excerpt

A major complication of autologous stem cell transplantation (ASCT) is the development of therapy-related myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML). This complication likely results from previous exposure of the autologous stem cells to chemotherapy as well as to the high doses of chemotherapy and radiation therapy that are used as part of the conditioning regimen. A number of centers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leukemia, Myeloid, Acute
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myelodysplastic Syndromes

Share to Neoplasms, Second Primary

Share to Risk Factors

Share to Stem Cell Transplantation

Share to Transplantation, Autologous

Share to Transplantation Conditioning

Source

Identifiers

PMID: 11846355
DOI: 10.1053/bbmt.2002.v8.pm11846355

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the risk of therapy-related MDS/AML after autologous stem cell transplantation.PMID 11846355Read ↗

The current and future role of stem cells in myelodysplastic syndrome therapies.Semantic proximity Read ↗

Therapy-related myelodysplastic syndrome.Semantic proximity Read ↗

Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post–autologous stem cell transplantationSemantic proximity Read ↗

Monitoring and treatment of MDS in genetically susceptible persons.Semantic proximity Read ↗

Therapy-related myelodysplasia and acute myeloid leukemia.Semantic proximity Read ↗

Therapy-related myeloid leukemia.Semantic proximity Read ↗

Genetics of therapy-related myelodysplasia and acute myeloid leukemia.Semantic proximity Read ↗

Treatment-related myelodysplastic syndrome: molecular characteristics and therapy.Semantic proximity Read ↗

Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.Semantic proximity Read ↗

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago seriesSemantic proximity Read ↗

Susceptibility to therapy-related myelodysplastic syndromes and acute myeloid leukemia.Semantic proximity Read ↗

Relapse assessment following allogeneic SCT in patients with MDS and AML.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.